Header Logo

Connection

STEPHEN HAHN to Doxorubicin

Back to Details
This is a "connection" page, showing publications STEPHEN HAHN has written about Doxorubicin.
STEPHEN HAHN
Connection Strength
0.328
Doxorubicin
  1. Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid. Int J Oncol. 2003 Jul; 23(1):159-63.
    View in: PubMed
    Score: 0.138
  2. A multidrug-resistant breast cancer cell line induced by weekly exposure to doxorubicin. Int J Oncol. 1999 Feb; 14(2):273-9.
    View in: PubMed
    Score: 0.101
  3. Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro. Cancer. 1993 Nov 01; 72(9):2705-11.
    View in: PubMed
    Score: 0.070
  4. Free radical modes of cytotoxicity of adriamycin and streptonigrin. Biochem Pharmacol. 1994 Oct 07; 48(7):1427-35.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.